Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
search results for:
Brent Saunders
Search
It was the best of all possible worlds in the worst of all times for biotech in 2020. What comes now?
5 years ago
Financing
Sierra Oncology brings on former Aimmune CEO to the helm; Flagship woos ex-Novartis exec Fabrice Chouraqui
5 years ago
Peer Review
Novartis' Cosentyx misses main goal in head-to-head trial with AbbVie's Humira
6 years ago
R&D
The $102B club: The top 15 R&D spenders in the global biopharma business — 2019 edition
6 years ago
R&D
Special
AbbVie uncoupling costs Reata $330M in cold, hard cash
6 years ago
Deals
AbbVie gets its FDA OK for JAK inhibitor upadacitinib, but don’t look for this one to hit execs’ lofty ...
6 years ago
R&D
Whale watching: What a decade of change at Big Pharma taught us about corporate phenotypes
7 years ago
Deals
Biotech Voices
Positive ocular implant data bring Allergan one step closer to NDA; Vivek Ramaswamy spawns another 'Vant'
7 years ago
News Briefing
Eyeing a blockbuster migraine market, Allergan takes an inside track on acute cases with positive PhIII
8 years ago
R&D
Expansive Sosei lays out a $534M acquisition plan for the ambitious saRNA biotech MiNA
9 years ago
Pharma
Did President Trump just jump the shark on drug prices?
9 years ago
Pharma
Biotech execs slam Trump’s travel ban, counting the high cost to a global industry
9 years ago
Pharma
Allergan aces another promising PhIII on uterine fibroid therapy, with plans to hustle the bundle to the FDA
9 years ago
R&D
These 300(+) Biotech Twitter citizens are the quickest to tweet news
9 years ago
Bioregnum
Special
First page
Previous page
8
9
10
11
latest
Most read
Updated: Trump administration reveals 'most favored nation' drug price country targets
20 hours ago
Pharma
Law
Altos Labs buys anti-aging startup Dorian Therapeutics
2 hours ago
Startups
Deals
Reproductive health biotech ReproNovo closes $65M Series A
2 hours ago
Financing
Startups
UK biotech Juvenescence targets $150M+ for 'healthy lifespan' drug candidates
4 hours ago
Financing
Startups
In his first major policy rollout, Vinay Prasad looks to challenge existing 'dogma' on Covid vaccines
14 hours ago
R&D
FDA+
see latest stream
